# Clinical Usefulness of Virtual Antiarrhythmic Drug Test in Patients With Recurred AF After Catheter Ablation(CUVIA-AF3)

> **NCT04223310** · NA · UNKNOWN · sponsor: **Yonsei University** · enrollment: 300 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** Virtual AAD TEST group
- **DRUG:** Empirical AAD group

## Key facts

- **NCT ID:** NCT04223310
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-06-13
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2023-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04223310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04223310, "Clinical Usefulness of Virtual Antiarrhythmic Drug Test in Patients With Recurred AF After Catheter Ablation(CUVIA-AF3)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04223310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*